PRINTER'S NO. 1387

THE GENERAL ASSEMBLY OF PENNSYLVANIA

HOUSE BILL

No. 650 Session of 1999

        INTRODUCED BY MICOZZIE, ADOLPH, CIVERA, DeLUCA, VANCE,
           E. Z. TAYLOR, BUXTON, CHADWICK, GODSHALL, KENNEY, MELIO,
           RAYMOND, PESCI, SATHER, BARRAR, BEBKO-JONES, BELARDI,
           BELFANTI, BISHOP, BUNT, CAPPABIANCA, L. I. COHEN, M. COHEN,
           COLAFELLA, CURRY, DAILEY, DALEY, FRANKEL, FREEMAN, GEORGE,
           GORDNER, HALUSKA, HARHAI, HARHART, HENNESSEY, HERMAN, HESS,
           HORSEY, HUTCHINSON, JAMES, JOSEPHS, LAUGHLIN, LEDERER, LUCYK,
           LYNCH, MAJOR, MARSICO, McCALL, S. MILLER, MYERS, NAILOR,
           ORIE, PETRARCA, READSHAW, RUBLEY, SANTONI, SAYLOR, SCHULER,
           SERAFINI, SEYFERT, SHANER, SOLOBAY, STABACK, STERN, SURRA,
           THOMAS, TIGUE, TRELLO, TRUE, WILLIAMS AND WOJNAROSKI,
           APRIL 13, 1999

        REFERRED TO COMMITTEE ON INSURANCE, APRIL 13, 1999

                                     AN ACT

     1  Amending the act of April 22, 1994 (P.L.136, No.20), entitled
     2     "An act mandating health insurance coverage of annual
     3     gynecological examinations and routine pap smears; and making
     4     repeals," further providing for legislative findings and for
     5     mandated coverage.

     6     The General Assembly of the Commonwealth of Pennsylvania
     7  hereby enacts as follows:
     8     Section 1.  Sections 2 and 4 of the act of April 22, 1994
     9  (P.L.136, No.20), known as the Women's Preventative Health
    10  Services Act, are amended by adding paragraphs to read:
    11  Section 2.  Declaration of policy.
    12     The General Assembly finds and declares as follows:
    13     * * *
    14     (8)  Technological advances in medical science have led to

     1  the development of newer tests which yield results superior to
     2  those obtained with the conventional cerviocovaginal
     3  papanicolaou test or pap smear.
     4     (9)  In 1996, the United Stated Food and Drug Administration
     5  approved the fluid-based, thin-layer preparation test as a
     6  replacement for the conventional cerviocovaginal papanicolaou
     7  test or pap smear.
     8  Section 4.  Mandated coverage.
     9     A health insurance policy which is delivered, issued for
    10  delivery, renewed, extended or modified in this Commonwealth by
    11  a health care insurer shall provide that the health insurance
    12  benefits applicable under the policy include coverage for
    13  periodic health maintenance to include:
    14         * * *
    15         (3)  Other cervical cancer screening methods approved by
    16     the United States Food and Drug Administration. Such
    17     screening shall include fluid-based, thin-layer preparation
    18     tests.
    19     Section 3.  This act shall take effect in 120 days.








    B10L40JS/19990H0650B1387         - 2 -